Table 3. Risk of 30 day Mortality for Women Compared with Men, Following ACS in the Overall Cohort (n=136,247).

	Event Rates		Odds Ratio (95% Confidence Interval)
	Women	Men	Unadjusted	Adjusted
All ACS	3654/37904 9.6%	5166/97768 5.3%	1.91 (1.83, 2.00)	1.06 (0.99, 1.15)
STEMI	3198/25903 12.3%	4385/75577 5.8%	2.29 (2.18, 2.40)*	1.15 (1.06, 1.24)*†
NSTEMI	265/4156 6.4%	9850/10297 4.3%	1.50 (1.28, 1.75)*	0.77 (0.63, 0.95)*
Unstable Angina	191/7845 2.4%	334/11894 2.8%	0.86 (0.72, 1.03)*	0.55 (0.43, 0.70)*†

Abbreviations: ACS, acute coronary syndromes; STEMI, ST segment elevation myocardial infarction; NSTEMI, non-STEMI

Odds ratios of female vs. male and 95% CI obtained through logistic regression including the following covariates: Age, Killip class, interaction between age and Killip class, heart rate, systolic blood pressure, weight, height, history of CHF, history of MI, history of CABG, history of diabetes, history of PCI, history of hypertension, current smoking status, and former smoking status along with type of ACS

^*Includes ACS*sex interaction to obtain the sex effect conditional on ACS categories

^†Statistically significant difference in overall mortality at 30 days between women and men under the Bonferroni-adjusted significance level 0.005 (= .05/10)